Hikma Pharmaceuticals PLC (LON:HIK)
London · Delayed Price · Currency is GBP · Price in GBX 1,568.00
+48.00 (3.16%)
At close: Jan 22, 2026
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 3.37 billion as of January 22, 2026. Its market cap has decreased by -26.38% in one year.
Market Cap
3.37B
Enterprise Value
4.34B
Revenue
2.35B
Ranking
n/a
PE Ratio
12.48
Stock Price
1,568.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 3.37B, an increase of 616.74%. That is a compound annual growth rate of 10.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.37B | -1.94% |
| Dec 31, 2025 | 3.43B | -22.33% |
| Dec 31, 2024 | 4.42B | 11.74% |
| Dec 29, 2023 | 3.96B | 15.72% |
| Dec 30, 2022 | 3.42B | -33.45% |
| Dec 31, 2021 | 5.14B | -11.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.16B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |
| Oxford Nanopore Technologies | 1.46B |